Gout is a relatively complex arthritic disease, and whether or not a patient with gout can receive the New Crown vaccine is determined by the stage of the patient’s condition. If a patient is currently in the acute phase of gout, with symptoms such as redness, swelling and pain in the joints, he or she should first be treated for the disease and wait until his or her condition stabilizes before receiving the New Crown vaccine to avoid aggravating the disease and causing adverse effects on the body. However, if the patient is in the stable stage of gout and has no other contraindications to vaccination, he or she can consider receiving the New Crown vaccine normally. Patients who are allergic to the components of the vaccine or who have had severe allergic reactions to the vaccine in the past should be strictly prohibited from receiving the New Crown vaccine. In addition, women during pregnancy, patients with severe neurological disease, and patients with fever, acute illness, acute exacerbation of chronic disease, or severe uncontrolled chronic disease should not receive the vaccine. Patients can receive the New Crown vaccine after the relevant diseases are controlled and stabilized.